Straits Times Index
3,306.02 +6.02 (+0.18%) Nikkei
38,596.47 -36.55 (-0.09%) Hang Seng
18,028.52 -306.80 (-1.67%) FTSE 100
8,237.72 -34.74 (-0.42%) Bitcoin USD
64,400.36 +145.68 (+0.23%) CMC Crypto 200
1,351.70 -8.62 (-0.63%)
TMO Mar 2025 860.000 call
| Previous close | 1.2000 |
| Open | 1.1000 |
| Bid | 0.0000 |
| Ask | 4.8000 |
| Strike | 860.00 |
| Expiry date | 2025-03-21 |
| Day's range | 1.1000 - 1.3000 |
| Contract range | N/A |
| Volume | |
| Open interest | 12 |
ZacksThermo Fisher (TMO) Unveils New Research Laboratory in WI
Thermo Fisher (TMO) announces a new 72,500-square-foot clinical research laboratory building at its good manufacturing practices lab in Middleton, WI
ZacksThermo Fisher's (TMO) New Buyouts Aid Growth, FX Issues Stay
Thermo Fisher's (TMO) business strategy primarily includes expansion through strategic acquisition of technologies and businesses that augment the company's existing products and services.
Business WireThermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink
WALTHAM, Mass., June 20, 2024--Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher"), the world leader in serving science, announced that its wholly owned subsidiary, Orion Acquisition AB (the "Buyer"), has extended the expiration time of the offering period of its previously announced tender offer (the "Offer") to acquire all of the outstanding common shares ("Shares") and all of the outstanding American Depositary Shares, each representing one Share ("ADSs"), of Olink Holding AB (publ) (
